Assay and drug development technologies

Assay and drug development technologies
期刊缩写:
ASSAY Drug Dev. Technol.
影响因子:
1.6
ISSN:
print: 1540-658X
on-line: 1557-8127
研究领域:
医学-生化研究方法
创刊年份:
2002年
h-index:
52
自引率:
0.00%
Gold OA文章占比:
2.04%
原创研究文献占比:
88.89%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts
CiteScore:
CiteScoreSJRSNIPCiteScore排名
3.60.3170.525
学科
排名
百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
100 / 157
36%
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Medicine
126 / 178
29%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
4区 医学
4区 生化研究方法 BIOCHEMICAL RESEARCH METHODS
4区 药学 PHARMACOLOGY & PHARMACY
WOS期刊分区
学科分类
Q4BIOCHEMICAL RESEARCH METHODS
Q3PHARMACOLOGY & PHARMACY
历年影响因子
2015年1.6550
2016年2.1960
2017年1.5930
2018年1.4200
2019年1.1870
2020年1.7380
2021年2.4710
2022年1.8000
2023年1.6000
历年发表
2012年51
2013年56
2014年53
2015年78
2016年68
2017年44
2018年52
2019年41
2020年49
2021年64
2022年33
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
UNITED STATES
审稿时长:
>12 weeks
出版商:
Mary Ann Liebert Inc.
编辑部地址:
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Assay and drug development technologies - 最新文献

Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.

Pub Date : 2024-11-06 DOI: 10.1089/adt.2024.029 Deepa Sugumar, Ritaban Ghosh, Emdormi Rymbai, Jaikanth Chandrasekaran, Praveen Thaggikuppe Krishnamurthy, Ranjith S P, Shreya Sahu, Divakar Selvaraj

Drug Repurposing Patent Applications: April-June 2024.

Pub Date : 2024-10-01 DOI: 10.1089/adt.2024.081 Hermann A M Mucke
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信